Tekmira Pharmaceuticals Corp Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 16 of 18 Posts
1 2
E Tekmira Sells Off After Ending Ebola Drug Program
Article By: Terry Chrisomalis Friday, June 19, 2015 9:21 PM EDT
Shares of Tekmira fall 11% after reporting that the company will stop one of its Ebola Drug programs after a preliminary analysis concluded the drug wouldn't succeed.
In this article: TKMR
Read
E Tekmira Gets The Go-Ahead From The FDA To Continue Its Ebola Drug Study
Article By: Terry Chrisomalis Friday, April 10, 2015 11:52 AM EDT
FDA had put a hold on testing in healthy volunteers, which can now resume.
In this article: TKMR
Read
3 Biotechs Looking Good This Earnings Season
Article By: Zacks Investment Research Saturday, January 31, 2015 3:55 PM EDT
It would be a good idea to zero in on a handful of biotech stocks that are poised to beat earnings estimates this quarter. An earnings beat should help these stocks gain investor confidence and show price improvement.
In this article: ARIA, BCRX, PCYC, GILD, ABBV, ESRX, SHPG, NPSP, AGEN, INCY, AZN, ICPT, TKMR, CMRX
Read
Tekmira Pharmaceuticals Shares Soar 57% After Merger Agreement With OnCore Biopharma
Article By: Terry Chrisomalis Tuesday, January 13, 2015 11:55 AM EDT
Oncore Biopharma to become wholly-owned subsidiary of Tekmira after the transaction completes.
In this article: TKMR
Read
E Rxi Pharmaceuticals Offers Great Risk-Reward Scenario Before Major Catalysts
Article By: Terry Chrisomalis Friday, November 14, 2014 11:05 AM EDT
Rxi Pharmaceuticals is extremely undervalued should approaching catalysts fulfill promise.
In this article: TKMR, RXII, RGLS
Read
Thinking Differently About Ebola Virus Disease: WBB Securities' Steve Brozak
Article By: The Life Sciences Report Friday, November 14, 2014 6:49 AM EDT
Mdtech analyst that has allowed the WBB Securities cofounder to develop a reasoned perspective on how West Africa's Ebola epidemic might be humanely halted. Brozak also mentions small-cap names that could considerably enhance investors' portfolios.
In this article: GSK, JNJ, NBS, BCRX, OMER, TKMR, CEMP, SRPT, CMRX, TTPH, NAVB
Read
E Ebola's Financial Implications (Updated)
Article By: Mary Hunt Thursday, October 23, 2014 12:20 PM EDT
Even with human costs paramount, a global crisis has impact on investments.
In this article: AGN, BCS, GSK, JNJ, INO, BCRX, NLNK, TKMR, SRPT
Read
Tekmira And J&J’s Ebola Drugs Advance Towards Deployment In West Africa
Article By: Jake King Wednesday, October 22, 2014 9:07 AM EDT
Tekmira Pharmaceuticals (TKMR) and European drug developer Bavarian Nordic (BAVA.CO) are receiving significant attention in early trading on Wednesday morning with announcements that their two distinct approaches to Ebola, a therapeutic and vaccine respectively, are advancing.
In this article: BAVA.CO, JNJ, TKMR, CMRX
Read
E Tekmira Reports Early Results On Hepatitis B Drug
Article By: Terry Chrisomalis Wednesday, October 15, 2014 4:52 PM EDT
Tekmira reports pre-clinical results on Hepatitis B drug
In this article: BMY, TKMR
Read
Alnylam Keeps Making New Strides In RNAi Research
Article By: Terry Chrisomalis Tuesday, October 14, 2014 3:46 PM EDT
Alnylam posts positive phase 2 results in open-label study.
In this article: SNY, ALNY, TKMR
Read
RXi Pharmaceuticals Posts Positive Phase 2a 3-Month Results In Hypertrophic Scars
Article By: Terry Chrisomalis Tuesday, October 7, 2014 3:13 PM EDT
This validation is important because now the company is at a reduced risk investment level.
In this article: TKMR, ARWR, RXII
Read
Biotech Investors Gamble On Ebola Stocks
Article By: BioMedReports Tuesday, October 7, 2014 6:39 AM EDT
The recent outbreaks of Ebola in Africa and the first case found in the U.S. have also heightened the FDA’s awareness of disease outbreaks and the need for stronger safety measures, but nothing gets investors salivating more than constant media attention.
In this article: HEB, INO, TPIV, TKMR
Read
E “New Frontier Stocks” At Play In The Battle Against Ebola
Article By: M.E. Garza Sunday, October 5, 2014 10:34 AM EDT
Several public companies have thrown their hats into the Ebola pandemic conversation, but only some will perform well for investors day in and day out.
In this article: HEB, INO, TPIV, TKMR
Read
E Inovio Pharma Wants To Join The Ebola Party
Article By: Terry Chrisomalis Wednesday, September 24, 2014 10:33 PM EDT
Inovio Pharmaceuticals To Begin Ebola Vaccine Study in early 2015
In this article: INO, TKMR
Read
Healthcare Review: GENE, PGNX, RPRX, TKMR, THLD
Article By: BioMedReports Wednesday, September 24, 2014 12:30 PM EDT
U.S. stocks fell on Monday, with the Dow Jones Industrial Average stepping back from an all-time high, as uncertainty about China's growth injected caution into global markets.
In this article: GENE, PGNX, RPRX, TKMR, THLD
Read
Tekmira Pharmaceuticals Just Keeps On Shining With Ebola Drug
Article By: Terry Chrisomalis Tuesday, September 23, 2014 5:25 PM EDT
Tekmira surges on back to back news for Ebola drug, but that's not all the company has going for it.
In this article: TKMR
Read
1 to 16 of 18 Posts
1 2